ПАТОГЕНЕТИЧЕСКИЕ ВЗАИМОСВЯЗИ ВОСПАЛЕНИЯ, ДИСЛИПИДЕМИИ ПРИ АТЕРОТРОМБОТИЧЕСКОМ ПОРАЖЕНИИ ЭКСТРАКРАНИАЛЬНЫХ АРТЕРИЙ
##article.abstract##
Библиографические ссылки
Feigin V.L., et al. Global and regional burden of stroke during 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820.
Sacco R.L., et al. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke. 2021;52:e364– e467.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453.
Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695.
Libby P., et al. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–2138.
Ridker P.M., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843.
Ross R. Atherosclerosis — an inflammatory disease. N Engl J Med. 1999;340:115–126.
Goldstein L.B., et al. Guidelines for the primary prevention of stroke. Stroke. 2011;42:517–584.
Catapano A.L., et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020;41(1):111–188.
Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–1818.
Gupta A., et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke. 2013;44:3071–3077.
